The occurrence of repeat exposures to animal bite is quite common. Economic evaluations of such interventions are important tools for informing health policy.
Objective: A cost analysis was carried out to compare the re-exposure booster vaccination with serological test strategies with full Essen PEP treatment in re-exposure cases.
Methods: This retrospective study had been based on the data of last 10 years of an antirabies clinic.
Statistical Analysis: Frequency distribution with percentage proportion
Results: Overall, 2684(8.19%) out of 32735 cases had evidence of Re exposure of dog bite and in 962 (35.84%) cases, dog survived more than 10 days. Additional Re-exposure cases taking complete anti rabies vaccines were 626(27.4%). Cost benefit 495 per case if all Re exposure cases are treating as first exposure
Conclusion: Using the example of cost benefit analysis (CBA) of re-exposure animal bite case treatment by booster doses after RFFIT testing or as a PEP treatment (first exposure) we demonstrate that the PEP treatment in all animal bite cases have certainly cost evaluation with perspectives of covering total risk.
Implication: "Better and safer to over treat than under treat" in view of risk benefit analysis of rabies death in endemic India.